Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 ...
PayPal (NASDAQ:PYPL – Free Report) had its price objective reduced by Piper Sandler from $85.00 to $76.00 in a research note ...
Sprout Social (NASDAQ:SPT – Free Report) had its price target decreased by Piper Sandler from $29.00 to $27.00 in a research ...
Itron (NASDAQ:ITRI – Get Free Report) had its price target lifted by analysts at Piper Sandler from $119.00 to $124.00 in a ...
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target increased by analysts at Piper Sandler from $67.00 ...
Couchbase (NASDAQ:BASE – Get Free Report) had its target price upped by research analysts at Piper Sandler from $21.00 to $22 ...
Piper Sandler reaffirmed their overweight rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report ...
Guardant Health (NASDAQ:GH – Get Free Report) had its target price upped by Piper Sandler from $34.00 to $50.00 in a report ...
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target cut by stock analysts at Piper Sandler from $75.00 to $70 ...
Piper Sandler upgraded shares of ZoomInfo Technologies (NASDAQ:ZI – Free Report) from an underweight rating to a neutral rating in a research note released on Wednesday morning, MarketBeat reports.
Fintel reports that on February 26, 2025, Piper Sandler upgraded their outlook for ZoomInfo Technologies (NasdaqGS:ZI) from Underweight to Neutral. As of February 19, 2025, the average one-year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results